investigator_user investigator user funding collaborators pending menu bell message arrow_up arrow_down filter layers globe marker add arrow close download edit facebook info linkedin minus plus save share search sort twitter remove user-plus user-minus
  • Project leads
  • Collaborators

Pharmacogenetics of Phase II Drug Metabolizing Enzymes

Richard M Weinshilboum

2 Collaborator(s)

Funding source

National Institute of General Medical Sciences (NIH)

Liewei Wang

Mayo Clinic (Rochester)

Rochester, United States

Related projects

Aliccia Bollig-Fischer

The Molecular Link from Type 2 Diabetes to Breast Cancer

Breast

Raymond B Birge

Non-canonical signal pathway for Crk in breast cancer

Breast

Susan E Erdman

GI Tract Dysbiosis and Breast Cancer

Breast

Lalage Wakefield

Development of TGF-beta antagonists for cancer therapy

Breast

Zhiyuan Shen

Alternative Mechanisms to Inactivate p53 during Oncogenesis

Breast

Patricia Steeg

Molecular Biology of the Metastatic Phenotype

Breast

Pathology

Hugh S. Gannon

Extraordinary responder cell lines reveal unique targetable genetic dependencies

Breast

Susan L Teitelbaum

Breast Cancer Genomics in Windows of Susceptibility to Endocrine Disruptors

Breast

Stanley Lipkowitz

TRAIL-induced Cell Death in Breast Cancer Cells

Breast